FER mediated HGF-independent regulation of HGFR/MET activates RAC1-PAK1 pathway to potentiate metastasis in ovarian cancer.

Small GTPases
Gaofeng Fan

Abstract

Uncontrolled metastasis significantly contributes to high lethality of patients suffering from ovarian cancer. To date, the detailed molecular mechanisms which account for ovarian tumor cell spreading and metastasis remain largely unknown. In a recent study, we have demonstrated that aberrantly high expression of the non-receptor tyrosine kinase FER is responsible for ovarian tumor cell metastasis both in vitro and in vivo. Mechanistically, we indentified Hepatocyte Growth Factor Receptor HGFR/MET as a novel substrate of FER, and through which the kinase FER modulates ovarian cancer cell motility and invasiveness in a ligand-independent manner. We also observed aberrantly high expression of PAK1 kinase in cancer cells, and RNAi-mediated knockdown of FER kinase inactivated the RAC1-PAK1 signaling pathway and decreased metastatic potential of CAOV4 ovarian cancer cells. Overall, our study revealed a previously uncharacterized, pro-metastatic role of the kinase FER in ovarian cancer through the MET-RAC1-PAK1 pathway. Further efforts are essential to investigating beneficial outcomes towards targeting the RAC1-PAK1 signaling pathway in reducing metastatic burden of this deadly disease.

References

Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S GiordanoP M Comoglio
Dec 28, 1999·Molecular and Cellular Biology·A SchürmannG M Bokoch
May 8, 2002·Nature Reviews. Molecular Cell Biology·Peter Greer
Sep 17, 2004·Genes & Development·Felix H BrembeckWalter Birchmeier
May 6, 2005·Molecular Biology of the Cell·David García-BernalJoaquin Teixidó
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Aron B Jaffe, Alan Hall
Mar 5, 2008·Genes, Chromosomes & Cancer·Lindsay A BrownDavid G Huntsman
Aug 23, 2008·Nature Reviews. Molecular Cell Biology·Sarah J Heasman, Anne J Ridley
May 23, 2009·Nature Reviews. Cancer·Robert C BastGordon B Mills
May 26, 2009·Oncogene·P R MolliR Kumar
Jul 21, 2009·Current Opinion in Cell Biology·Benjamin Boettner, Linda Van Aelst
Dec 25, 2009·Trends in Molecular Medicine·Xiangdong LiuPeggy A Scherle
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael S GordonLia Gore
Mar 8, 2011·Cell·John G Albeck, Joan S Brugge
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Andrew W B Craig
Jan 25, 2012·Nature Reviews. Cancer·Ermanno GherardiGeorge Vande Woude
Jun 26, 2012·Cancer Metastasis Reviews·Rémi LonguespéeMichel Salzet
May 24, 2013·Molecular Cancer Research : MCR·Joseph AhnAndrew W B Craig
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Nov 2, 2019·Journal of Cellular Physiology·Tao XuShu-Kui Wang
Jun 4, 2021·Frontiers in Oncology·Jiaxin LiangQianjin Liao
Aug 11, 2020·Cancer Metastasis Reviews·Rui-Jie ZengEn-Min Li

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
GTPases
GTPase
xenograft

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.